Little is known about the role, extent, or effects of family member involvement in monitoring and managing opioid analgesics. Knowing when or how family members monitor prescribed opioid medication taking, whether it is acceptable to patients, or how family relationships may be affected by monitoring, are not well documented.
Methods
The study was conducted at Kaiser Permanente Northwest, an integrated health plan in Oregon and Washington. Semistructured in-depth interviews (N = 87) assessed circumstances surrounding overdose events among individuals who either experienced an opioid-related overdose or were family members of patients who died as a result of such an overdose. A subset of participants (n = 20) described family members’ roles in monitoring opioid medications before or after overdoses. Interviews were transcribed verbatim and coded using Atlas.ti. We used a modified grounded theory approach to categorize emergent data and to identify common themes.
Results
When family members played roles in monitoring and managing opioid medications, clinicians were often unaware of their involvement. Patients and family members reported better outcomes when the patient, caregiver, and clinician developed a shared treatment plan. Negative outcomes included relationship stress, particularly when patients and caregivers had differing perspectives about what constituted effective pain management versus misuse and abuse.
Conclusions
When families are concerned about opioid medications, coordination between clinicians, patients, and family carers appears to clarify roles and foster better outcomes. Increased stress and worse outcomes were reported when clinicians were not actively involved and when they did not attend to carers’ concerns.
Substance Abuse and Mental Health Services Administration. Results From the 2012 National Survey on Drug Use and Health: Mental Health Findings. Rockville, MD: Office of Applied Studies, Substance Abuse and Mental Health Services Administration; 2013. NSDUH Series H-47, HHS Publication No. (SMA)13–4805.
2.
Centers for Disease Control and Prevention. Emergency department visits involving nonmedical use of selected prescription drugs—United States, 2004–2008. MMWR Morb Mort Wkly Rep.2010;59:705–709.
3.
Centers for Disease Control and Prevention. Overdose deaths involving prescription opioids among Medicaid enrollees—Washington, 2004–2007. MMWR Morb Mort Wkly Rep.2009;58:1171–1175.
4.
JohnsonEM, LanierWA, MerrillRM, . Unintentional prescription opioid-related overdose deaths: description of decedents by next of kin or best contact, Utah, 2008–2009. J Gen Intern Med.2013;28:522–529.
5.
Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mort Wkly Rep.2011;60:1487–1492.
6.
WarnerM, ChenLH, MakucDM, AndersonRN, MininoAM. Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief.2011;(81):1–8.
7.
ChouR, FanciulloGJ, FinePG, . Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain.2009;10:113–130.
8.
LingW, MooneyL, HillhouseM. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev.2011;30:300–305.
9.
PergolizziJ, BogerRH, BuddK, . Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract.2008;8:287–313.
10.
ButlerSF, BudmanSH, FernandezK, JamisonRN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain.2004;112:65–75.
11.
ButlerSF, FernandezK, BenoitC, BudmanSH, JamisonRN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain.2008;9:360–372.
12.
ChouR, FanciulloGJ, FinePG, MiaskowskiC, PassikSD, PortenoyRK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain.2009;10:131–146.
13.
ButlerSF, BudmanSH, FernandezKC, . Development and validation of the Current Opioid Misuse Measure. Pain.2007;130:144–156.
14.
GreenTC, BlackR, Grimes SerranoJM, BudmanSH, ButlerSF. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS ONE.2011;6:e27244.
15.
RiceJB, WhiteAG, BirnbaumHG, SchillerM, BrownDA, RolandCL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med.2012;13:1162–1173.
16.
SolankiDR, KoyyalaguntaD, ShahRV, SilvermanSM, ManchikantiL. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician.2011;14:E119–E131.
17.
TraftonJA, CucciareMA, LewisE, OserM. Somatization is associated with non-adherence to opioid prescriptions. J Pain.2011;12:573–580.
18.
PesceA, WestC, GonzalesE, . Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine. Pain Physician.2012;15:E687–E692.
19.
WestR, PesceA, WestC, . Observations of medication compliance by measurement of urinary drug concentrations in a pain management population. J Opioid Manage.2010;6:253–257.
20.
MartireLM, SchulzR, HelgesonVS, SmallBJ, SaghafiEM. Review and meta-analysis of couple-oriented interventions for chronic illness. Ann Behav Med.2010;40:325–342.
21.
DimatteoMR.Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol.2004;23:207–218.
22.
MartireLM, LustigAP, SchulzR, MillerGE, HelgesonVS. Is it beneficial to involve a family member? A meta-analysis of psychosocial interventions for chronic illness. Health Psychol.2004;23:599–611.
23.
NguyenLM, RhondaliW, De la CruzM, . Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. J Pain Symptom Manage.2013;45:506–516.
24.
SandersS, HerrKA, FinePG, FialaC, TangX, ForcucciC. An examination of adherence to pain medication plans in older cancer patients in hospice care. J Pain Symptom Manage.2013;45:43–55.
25.
DakofGA, TaylorSE. Victims’ perceptions of social support: what is helpful from whom?J Pers Soc Psychol.1990;58:80–89.
26.
GillespieR, MullanJ, HarrisonL. Managing medications: the role of informal caregivers of older adults and people living with dementia. A review of the literature. J Clin Nurs.2014;23:3296–3308.
27.
WolffJL, SpillmanB. Older adults receiving assistance with physician visits and prescribed medications and their family caregivers: prevalence, characteristics, and hours of care. J Gerontol B Psychol Sci Soc Sci.2014;69(Suppl 1):S65–S72.
28.
TrivediRB, BrysonCL, UdrisE, AuDH. The influence of informal caregivers on adherence in COPD patients. Ann Behav Med.2012;44:66–72.
29.
StrombergA.The situation of caregivers in heart failure and their role in improving patient outcomes. Curr Heart Fail Rep.2013;10:270–275.
30.
AugustKJ, RookKS, FranksMM, Parris StephensMA. Spouses’ involvement in their partners’ diabetes management: associations with spouse stress and perceived marital quality. J Fam Psychol.2013;27:712–721.
31.
MillerTA, DimatteoMR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes.2013;6:421–426.
32.
KulharaP, KateN, GroverS, NehraR. Positive aspects of caregiving in schizophrenia: a review. World J Psychiatry.2012;2:43–48.
33.
WrubelJ, StumboS, JohnsonMO. Male same sex couple dynamics and received social support for HIV medication adherence. J Soc Pers Relat.2010;27:553–572.
34.
JohnsonMO, DilworthSE, TaylorJM, DarbesLA, ComfortML, NeilandsTB. Primary relationships, HIV treatment adherence, and virologic control. AIDS Behav.2012;16:1511–1521.
35.
WrubelJ, StumboS, JohnsonMO. Antiretroviral medication support practices among partners of men who have sex with men: a qualitative study. AIDS Patient Care STDS.2008;22:851–858.
36.
FrancisSA, SmithF, GrayN, DenhamM. Partnerships between older people and their carers in the management of medication. Int J Older People Nurs.2006;1:201–207.
37.
WhileC, DuaneF, BeanlandC, KochS. Medication management: the perspectives of people with dementia and family carers. Dementia (London).2013;12:734–750.
38.
AugustKJ, RookKS, StephensMA, FranksMM. Are spouses of chronically ill partners burdened by exerting health-related social control?J Health Psychol.2011;16:1109–1119.
39.
ReinhardtJP, BoernerK, HorowitzA. Good to have but not to use: differential impact of perceived and received support on well-being. J Soc Pers Relationsh.2006;23:117–129.
40.
ThorpeJM, ThorpeCT, KenneltyKA, GelladWF, SchulzR. The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia. Am J Geriatr Pharmacother.2012;10:230–241.
41.
EdlundMJ, MartinBC, FanMY, DevriesA, BradenJB, SullivanMD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend.2010;112:90–98.
42.
EdlundMJ, MartinBC, RussoJE, DeVriesA, BradenJB, SullivanMD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain.2014;30:557–564.
43.
AlexanderL, MannionRO, WeingartenB, FanelliRJ, StilesGL. Development and impact of prescription opioid abuse deterrent formulation technologies. Drug Alcohol Depend.2014;138:1–6.
44.
SevertsonSG, BartelsonBB, DavisJM, . Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain.2013;14:1122–1130.
45.
WarnerM, ChenLH, MakucDM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief.2009;(22):1–8.
46.
JanoffSL, PerrinNA, CoplanPM, ChilcoatHD, CampbellCI, GreenCA. Study protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. BMC Pharmacol Toxicol. Under review.
GlaserBG, StraussAL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine Publishing Company; 1967.
49.
SaldañaJ.The Coding Manual for Qualitative Researchers. London: Sage; 2009.
50.
StraussA, CorbinJ. Grounded theory methodology: an overview. In: DenzinNK, LincolnYS, eds. Strategies of Qualitative Inquiry. Thousand Oaks, CA: Sage Publications; 1998:158–183.
51.
StarrelsJL, WuB, PeyserD, . It made my life a little easier: primary care providers’ beliefs and attitudes about using opioid treatment agreements. J Opioid Manage.2014;10:95–102.
52.
FishmanSM, BandmanTB, EdwardsA, BorsookD. The opioid contract in the management of chronic pain. J Pain Symptom Manage.1999;18:27–37.
53.
LewisMA, ButterfieldRM. Antecedents and reactions to health-related social control. Pers Soc Psychol Bull.2005;31:416–427.
54.
RookKS, AugustKJ, StephensMAP, FranksMM. When does spousal social control provoke negative reactions in the context of chronic illness? The pivotal role of patients’ expectations. J Soc Pers Relationsh.2011;28:772–789.
55.
MueserKT, GingerichS. Treatment of co-occurring psychotic and substance use disorders. Soc Work Public Health.2013;28:424–439.
56.
KlostermannK, O'FarrellTJ. Treating substance abuse: partner and family approaches. Soc Work Public Health.2013;28:234–247.
